Terodiline inhibition of human bladder contraction. Effects in vitro and in women with unstable bladder

Publisher Website
Google Scholar
Abstract
Terodiline, a drug with anticholinergic and Ca antagonistic properties, effectively relaxed carbachol-contracted, isolated human bladder preparations. In the concentrations used, terodiline displaced to the right the concentration-response curve obtained on cumulative addition of carbachol. The maximum response was slightly reduced only at the highest terodiline concentration used (5 .mu.M), suggesting a mainly competitive antimuscarinic effect. Nine patients, 12-78 yr old, suffering from urge urinary incontinence were investigated by simultaneous urethro-cystometry before and after treatment with terodiline 12.5 mg twice or 3 times daily for 10 days. The patients reported subjective improvement with almost no side effects. Objectively, the number of uninhibited bladder contractions and the amplitude of the contractions decreased. The bladder capacity was almost doubled. There were no marked effects on bladder and urethral pressures at rest, and only 2 of the investigated patients had slight residual urine after treatment. Terodiline is a promising alternative to existing drugs for inhibition of undesired detrusor activity.